Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?

Mike P. Wattjes, Clemens Warnke

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number115
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume87
Issue number2
DOIs
Publication statusPublished - Feb 2016

Cite this